0001209191-14-027714.txt : 20140415
0001209191-14-027714.hdr.sgml : 20140415
20140415204510
ACCESSION NUMBER: 0001209191-14-027714
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140414
FILED AS OF DATE: 20140415
DATE AS OF CHANGE: 20140415
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000891288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330476164
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1300 NORTH KELLOGG DRIVE
STREET 2: SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92807
BUSINESS PHONE: 714-786-4200
MAIL ADDRESS:
STREET 1: 1300 NORTH KELLOGG DRIVE
STREET 2: SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92807
FORMER COMPANY:
FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAILEY DON M
CENTRAL INDEX KEY: 0001223697
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14758
FILM NUMBER: 14766321
MAIL ADDRESS:
STREET 1: 1300 N. KELLOGG DRIVE
STREET 2: SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92607
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-04-14
0
0000891288
QUESTCOR PHARMACEUTICALS INC
QCOR
0001223697
BAILEY DON M
1300 NORTH KELLOGG DRIVE
SUITE D
ANAHEIM
CA
92807
1
1
0
0
President and CEO
Common Stock
2014-04-14
4
M
0
40000
5.12
A
139000
I
Held by the Bailey 1995 Family Trust
Common Stock
2014-04-14
4
S
0
13899
78.1683
D
125101
I
Held by the Bailey 1995 Family Trust
Common Stock
2014-04-14
4
S
0
5300
79.6558
D
119801
I
Held by the Bailey 1995 Family Trust
Common Stock
2014-04-14
4
S
0
18754
80.551
D
101047
I
Held by the Bailey 1995 Family Trust
Common Stock
2014-04-14
4
S
0
2047
81.5331
D
99000
I
Held by the Bailey 1995 Family Trust
Stock Option (right to buy)
5.12
2014-04-14
4
M
0
40000
0.00
D
2020-01-18
Common Stock
40000
180000
I
Held by the Bailey 1995 Family Trust
As of the date of this Form 4, the reporting person holds Questcor Pharmaceuticals, Inc. stock options to purchase 905,000 shares of common stock; of such amount, 745,103 shares are fully vested and exercisable. The reporting person also holds 377,237 shares of Questcor Pharmaceuticals, Inc. common stock, of which 278,237 shares are held directly by the reporting person.
Options were granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan.
The option was granted on 01/19/2010 for the right to buy 280,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant, with a 12-month cliff, whereby no options vested until after the twelfth month from the date of the grant.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 - $78.74, $79.11 - $80.10, $80.11 - $81.09 and $81.11 - $81.79, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan (the "Automatic Trading Plan") adopted by the reporting person in the second quarter of 2013 and effective 90 days post-adoption. There have been no changes to the Automatic Trading Plan since its adoption. The first sale under the Automatic Trading Plan occurred on September 13, 2013, and there have been no sales by the Reporting Person outside of the Automatic Trading Plan since its adoption. The Automatic Trading Plan controls the exact dates and amounts of sales.
/s/Don M. Bailey
2014-04-15